Evidence map›Paper›PMID 22195688›Full record

ArticleAllergy and asthma proceedings

C-027 inhibits IgE-mediated passive sensitization bronchoconstriction and acts as a histamine and serotonin antagonist in human airways.

Philip R Cooper, Jie Zhang, Gautam Damera, Toshinori Hoshi, David A Zopf, Reynold A Panettieri

Abstract read
In one paragraph

Article in Allergy and asthma proceedings. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Organotypic Models of Lung Cancer.Current topics in microbiology and immunology · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.American journal of physiology. Lung cellular and molecular physiology · 2015
    Article
  18. Persistence of serotonergic enhancement of airway response in a model of childhood asthma.American journal of respiratory cell and molecular biology · 2014
    Article
  19. Reproducible uniform equibiaxial stretch of precision-cut lung slices.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Philip R CooperDepartment of Medicine and the Airway Biology Initiative, University of Pennsylvania, Philadelphia, USA.
Jie Zhang
Gautam Damera
Toshinori Hoshi
David A Zopf
Reynold A Panettieri
University of Pennsylvania · US

Funding

REGULATION OF ION CHANNELS BY METHIONINE OXIDATIONR01GM057654 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI HOSHI, TOSHINORI, OLCESE, RICCARDO · 1998 to 2014
$5.0M
NIGMS NIH HHS R01 GM057654
6 · The paper itself

Abstract

Atopic asthma is poorly controlled by current therapies. Newer therapies and novel antihistamines are, therefore, required to treat patients whose atopic asthma is not controlled. For the first time, C-027 is shown to antagonize histamine, IgE-mediated and serotonin-induced contraction in human airways and vessels. Human precision-cut lung slices (PCLS, 250 μm thick), containing an airway or blood vessel, were pretreated with either C-027 (2 hours) or with vehicle alone and were contracted with histamine or serotonin. Known antihistamine was used as a comparator in antihistamine studies. Also, human airways were contracted via IgE passive sensitization in the presence or absence of C-027 or fexofenadine. Affinity of C-027 toward human G-protein coupled receptors was also determined, as well as the drug's biodistribution in murine model. C-027 was shown to have the highest affinity toward human histamine and serotonin receptors. Subsequently, C-027 was shown to antagonize histamine- and serotonin-induced airway and vascular smooth muscle contraction, respectively, and histamine-released bronchocontraction mediated by IgE passive sensitization in human small airways. C-027 also inhibited histamine-mediated single-cell calcium ion release. Low levels of C-027 were found in murine brain tissue. Collectively, these data suggest that C-027 markedly inhibits IgE-induced bronchoconstriction and antagonizes histamine and serotonin-contraction with little biodistribution in the brain. The compound may offer a future therapy for allergen-induced airway hyperresponsiveness in patients with asthma.

Indexed as

AcetamidesAnimalsBiological AvailabilityBronchial HyperreactivityBronchoconstrictionCalciumHistamineHistamine AntagonistsHumansHypersensitivity, ImmediateImmunoglobulin EMicePhenothiazinesPiperazinesReceptors, HistamineRespiratory System2-amino-N-(2-(4-(3-(2-trifluoromethylphenothiazin-10-yl)propyl)piperazin-1-yl)ethyl)acetamideAcetamidesCalciumHistamineHistamine AntagonistsImmunoglobulin EPhenothiazinesPiperazinesReceptors, HistamineSerotonin Antagonists

Identifiers

PMID22195688
PMCPMC3968313
OpenAlexW2313918590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.